Continuous Renal Replacement Therapy Market By Product (Systems, Consumables), By Modality (Continuous Veno-Venous Hemodiafiltration (CVVHDF), Continuous Veno-Venous Hemodialysis (CVVHD), Continuous Veno-Venous Hemofiltration (CVVH), Slow Continuous Ultrafiltration (SCUF), Therapeutic Plasma Exchange (TPE) ) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Acute renal failure is a rapid onset of renal function impairment which is potentially reversible depending on the cause and the extent of being untreated. Acute renal failure is a common condition experienced during critical illness and ICU admission. Mortality associated with ARF is high with approximately 50% patients dying. Continuous renal replacement therapy is a type of hemodialysis that was innovated by medical practitioners facing the restrictions of peritoneal dialysis and the delays in beginning intermittent hemodialysis. Need for transporting patients to dialysis unit for treatment leads to risk to the patients’ health and delaying necessary treatment. With additional advantage of having user friendly equipment, and better solute removal, CRRT has become widely adopted and appropriately suited for treatment in acute renal failure.

The purpose of this research study titled ‘Continuous Renal Replacement Therapy Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global continuous renal replacement therapy market. This report presents and analyzes the major trends prevalent in the global continuous renal replacement therapy market and the market size and forecast.

This report categorizes the global continuous renal replacement therapy market in terms of products, modality and geographical distribution. Based on product type, the global continuous renal replacement therapy market is categorized into systems and consumables. The consumables segment is further studied for filters, tubing sets and disposables. Additionally, continuous veno-venous hemodiafiltration (CVVHDF), continuous veno-venous hemodialysis (CVVHD), continuous veno-venous hemofiltration (CVVH), slow continuous ultrafiltration (SCUF), and therapeutic plasma exchange (TPE) are the dialysis modalities considered for the purpose of this study. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global continuous renal replacement therapy market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional analysis is presented in terms of product type, modality and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global continuous renal replacement therapy market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the continuous renal replacement therapy market. The key players profiled in this report are Asahi Kasei Corporation, Baxter International Inc., B. Braun Melsungen AG, BeLLCo S.R.L. (Medtronic PLC), Fresenius Medical Care AG & Co. KGaA, Medica SpA, Medites Pharma spol. Sro, NxStage Medical, Inc., NIPRO Corporation, SWS Hemodialysis Care Co. Ltd. and Toray Medical Co., Ltd.

Geographically, the global continuous renal replacement therapy market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Continuous Renal Replacement Therapy Market

North America comprising of country level markets of the U.S. and Canada is the largest regional market for continuous renal replacement therapy. High prevalence of acute renal diseases, greater adoption of novel filtration systems and better reimbursement system are the key growth contributors in the North America market. Greater awareness and significant prevalence of chronic diseases leading to admissions in ICU also drive the North America continuous renal replacement therapy market. On the other hand, it is expected that Asia Pacific market will witness the fastest growth on the global front. Increasing awareness in the general population and physicians, rapid rise in the number of hospitals due to evolution of healthcare infrastructure, and rising healthcare expenditure of the general patient population are expected to drive Asia Pacific continuous renal replacement therapy market.

The detailed regional classification of the global continuous renal replacement therapy market is as follows:

  • North America (U.S. & Canada)
  • Europe (U.K., Germany and Rest of Europe)
  • Asia Pacific (China, Japan, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
Choose License Type
Published Date:  Sep 2017
Category:  Medical Devices
Report ID:   58700
Report Format:   PDF
Pages:   120
Rating:    4.2 (55)
Connect With Us
+1-408-641-3282
24/7 Research Support